ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Lyme Disease Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-17K18234
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Veterinary Lyme Disease Vaccine Market Research Report 2024
BUY CHAPTERS

Global Veterinary Lyme Disease Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17K18234
Report
October 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Zoetis Inc
Merck
Bioveta
Elanco

Veterinary Lyme Disease Vaccine Market

The global Veterinary Lyme Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Veterinary Lyme disease vaccine refers to a vaccine product used to prevent Lyme disease in animals. Lyme disease, also known as Lyme borreliosis, is a tick-borne disease caused by species of Borrelia bacteria, transmitted by blood-feeding ticks in the genus Ixodes.
From a downstream perspective, Canine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Veterinary Lyme Disease Vaccine leading manufacturers including Boehringer Ingelheim, Zoetis, Merck, Bioveta, Elanco, etc., dominate supply; the top five capture approximately % of global revenue, with Boehringer Ingelheim leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Veterinary Lyme Disease Vaccine market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Veterinary Lyme Disease Vaccine Market Report

Report Metric Details
Report Name Veterinary Lyme Disease Vaccine Market
Segment by Type
  • Monovalent Vaccines
  • Combination Vaccines
Segment by Application
  • Canine
  • Feline
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Zoetis, Merck, Bioveta, Elanco
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Veterinary Lyme Disease Vaccine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Veterinary Lyme Disease Vaccine Market report?

Ans: The main players in the Veterinary Lyme Disease Vaccine Market are Boehringer Ingelheim, Zoetis, Merck, Bioveta, Elanco

What are the Application segmentation covered in the Veterinary Lyme Disease Vaccine Market report?

Ans: The Applications covered in the Veterinary Lyme Disease Vaccine Market report are Canine, Feline, Others

What are the Type segmentation covered in the Veterinary Lyme Disease Vaccine Market report?

Ans: The Types covered in the Veterinary Lyme Disease Vaccine Market report are Monovalent Vaccines, Combination Vaccines

1 Study Coverage
1.1 Introduction to Veterinary Lyme Disease Vaccine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Veterinary Lyme Disease Vaccine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Monovalent Vaccines
1.2.3 Combination Vaccines
1.3 Market Segmentation by Application
1.3.1 Global Veterinary Lyme Disease Vaccine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Canine
1.3.3 Feline
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Lyme Disease Vaccine Revenue Estimates and Forecasts 2020-2031
2.2 Global Veterinary Lyme Disease Vaccine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Veterinary Lyme Disease Vaccine Sales Estimates and Forecasts 2020-2031
2.4 Global Veterinary Lyme Disease Vaccine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Veterinary Lyme Disease Vaccine Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Veterinary Lyme Disease Vaccine Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Monovalent Vaccines Market Size by Manufacturers
3.5.2 Combination Vaccines Market Size by Manufacturers
3.6 Global Veterinary Lyme Disease Vaccine Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Veterinary Lyme Disease Vaccine Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Lyme Disease Vaccine Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Veterinary Lyme Disease Vaccine Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Veterinary Lyme Disease Vaccine Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Veterinary Lyme Disease Vaccine Sales and Revenue by Type (2020-2031)
6.4 North America Veterinary Lyme Disease Vaccine Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Veterinary Lyme Disease Vaccine Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Veterinary Lyme Disease Vaccine Sales and Revenue by Type (2020-2031)
7.4 Europe Veterinary Lyme Disease Vaccine Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Veterinary Lyme Disease Vaccine Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Veterinary Lyme Disease Vaccine Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Veterinary Lyme Disease Vaccine Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Veterinary Lyme Disease Vaccine Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Veterinary Lyme Disease Vaccine Sales and Revenue by Type (2020-2031)
9.4 Central and South America Veterinary Lyme Disease Vaccine Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Veterinary Lyme Disease Vaccine Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Veterinary Lyme Disease Vaccine Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Veterinary Lyme Disease Vaccine Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Veterinary Lyme Disease Vaccine Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Models, Descriptions and Specifications
11.1.4 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales by Product in 2024
11.1.6 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales by Application in 2024
11.1.7 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales by Geographic Area in 2024
11.1.8 Boehringer Ingelheim Veterinary Lyme Disease Vaccine SWOT Analysis
11.1.9 Boehringer Ingelheim Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Lyme Disease Vaccine Product Models, Descriptions and Specifications
11.2.4 Zoetis Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Zoetis Veterinary Lyme Disease Vaccine Sales by Product in 2024
11.2.6 Zoetis Veterinary Lyme Disease Vaccine Sales by Application in 2024
11.2.7 Zoetis Veterinary Lyme Disease Vaccine Sales by Geographic Area in 2024
11.2.8 Zoetis Veterinary Lyme Disease Vaccine SWOT Analysis
11.2.9 Zoetis Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview
11.3.3 Merck Veterinary Lyme Disease Vaccine Product Models, Descriptions and Specifications
11.3.4 Merck Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Merck Veterinary Lyme Disease Vaccine Sales by Product in 2024
11.3.6 Merck Veterinary Lyme Disease Vaccine Sales by Application in 2024
11.3.7 Merck Veterinary Lyme Disease Vaccine Sales by Geographic Area in 2024
11.3.8 Merck Veterinary Lyme Disease Vaccine SWOT Analysis
11.3.9 Merck Recent Developments
11.4 Bioveta
11.4.1 Bioveta Corporation Information
11.4.2 Bioveta Business Overview
11.4.3 Bioveta Veterinary Lyme Disease Vaccine Product Models, Descriptions and Specifications
11.4.4 Bioveta Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Bioveta Veterinary Lyme Disease Vaccine Sales by Product in 2024
11.4.6 Bioveta Veterinary Lyme Disease Vaccine Sales by Application in 2024
11.4.7 Bioveta Veterinary Lyme Disease Vaccine Sales by Geographic Area in 2024
11.4.8 Bioveta Veterinary Lyme Disease Vaccine SWOT Analysis
11.4.9 Bioveta Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Business Overview
11.5.3 Elanco Veterinary Lyme Disease Vaccine Product Models, Descriptions and Specifications
11.5.4 Elanco Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Elanco Veterinary Lyme Disease Vaccine Sales by Product in 2024
11.5.6 Elanco Veterinary Lyme Disease Vaccine Sales by Application in 2024
11.5.7 Elanco Veterinary Lyme Disease Vaccine Sales by Geographic Area in 2024
11.5.8 Elanco Veterinary Lyme Disease Vaccine SWOT Analysis
11.5.9 Elanco Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Veterinary Lyme Disease Vaccine Industry Chain
12.2 Veterinary Lyme Disease Vaccine Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Veterinary Lyme Disease Vaccine Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Veterinary Lyme Disease Vaccine Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Veterinary Lyme Disease Vaccine Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Veterinary Lyme Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Boehringer Ingelheim
Zoetis Inc
Merck
Bioveta
Elanco
List of Tables
 Table 1. Global Veterinary Lyme Disease Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Veterinary Lyme Disease Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Veterinary Lyme Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Veterinary Lyme Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Veterinary Lyme Disease Vaccine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Veterinary Lyme Disease Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Veterinary Lyme Disease Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Veterinary Lyme Disease Vaccine Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Veterinary Lyme Disease Vaccine Sales Share by Manufacturers (2020-2025)
 Table 12. Global Veterinary Lyme Disease Vaccine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Veterinary Lyme Disease Vaccine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Lyme Disease Vaccine as of 2024)
 Table 16. Global Veterinary Lyme Disease Vaccine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Veterinary Lyme Disease Vaccine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Veterinary Lyme Disease Vaccine Manufacturing Base and Headquarters
 Table 19. Global Veterinary Lyme Disease Vaccine Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Veterinary Lyme Disease Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Veterinary Lyme Disease Vaccine Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Veterinary Lyme Disease Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Veterinary Lyme Disease Vaccine Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Veterinary Lyme Disease Vaccine ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Veterinary Lyme Disease Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Veterinary Lyme Disease Vaccine Sales by Application (2026-2031) & (K Dose)
 Table 30. Veterinary Lyme Disease Vaccine High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Veterinary Lyme Disease Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Veterinary Lyme Disease Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Veterinary Lyme Disease Vaccine ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Veterinary Lyme Disease Vaccine Growth Accelerators and Market Barriers
 Table 37. North America Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Veterinary Lyme Disease Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Veterinary Lyme Disease Vaccine Growth Accelerators and Market Barriers
 Table 40. Europe Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Veterinary Lyme Disease Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Veterinary Lyme Disease Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Veterinary Lyme Disease Vaccine Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Veterinary Lyme Disease Vaccine Investment Opportunities and Key Challenges
 Table 47. Central and South America Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Veterinary Lyme Disease Vaccine Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Boehringer Ingelheim Corporation Information
 Table 51. Boehringer Ingelheim Description and Major Businesses
 Table 52. Boehringer Ingelheim Product Models, Descriptions and Specifications
 Table 53. Boehringer Ingelheim Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Boehringer Ingelheim Sales Value Proportion by Product in 2024
 Table 55. Boehringer Ingelheim Sales Value Proportion by Application in 2024
 Table 56. Boehringer Ingelheim Sales Value Proportion by Geographic Area in 2024
 Table 57. Boehringer Ingelheim Veterinary Lyme Disease Vaccine SWOT Analysis
 Table 58. Boehringer Ingelheim Recent Developments
 Table 59. Zoetis Corporation Information
 Table 60. Zoetis Description and Major Businesses
 Table 61. Zoetis Product Models, Descriptions and Specifications
 Table 62. Zoetis Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Zoetis Sales Value Proportion by Product in 2024
 Table 64. Zoetis Sales Value Proportion by Application in 2024
 Table 65. Zoetis Sales Value Proportion by Geographic Area in 2024
 Table 66. Zoetis Veterinary Lyme Disease Vaccine SWOT Analysis
 Table 67. Zoetis Recent Developments
 Table 68. Merck Corporation Information
 Table 69. Merck Description and Major Businesses
 Table 70. Merck Product Models, Descriptions and Specifications
 Table 71. Merck Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Merck Sales Value Proportion by Product in 2024
 Table 73. Merck Sales Value Proportion by Application in 2024
 Table 74. Merck Sales Value Proportion by Geographic Area in 2024
 Table 75. Merck Veterinary Lyme Disease Vaccine SWOT Analysis
 Table 76. Merck Recent Developments
 Table 77. Bioveta Corporation Information
 Table 78. Bioveta Description and Major Businesses
 Table 79. Bioveta Product Models, Descriptions and Specifications
 Table 80. Bioveta Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Bioveta Sales Value Proportion by Product in 2024
 Table 82. Bioveta Sales Value Proportion by Application in 2024
 Table 83. Bioveta Sales Value Proportion by Geographic Area in 2024
 Table 84. Bioveta Veterinary Lyme Disease Vaccine SWOT Analysis
 Table 85. Bioveta Recent Developments
 Table 86. Elanco Corporation Information
 Table 87. Elanco Description and Major Businesses
 Table 88. Elanco Product Models, Descriptions and Specifications
 Table 89. Elanco Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Elanco Sales Value Proportion by Product in 2024
 Table 91. Elanco Sales Value Proportion by Application in 2024
 Table 92. Elanco Sales Value Proportion by Geographic Area in 2024
 Table 93. Elanco Veterinary Lyme Disease Vaccine SWOT Analysis
 Table 94. Elanco Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Veterinary Lyme Disease Vaccine Product Picture
 Figure 2. Global Veterinary Lyme Disease Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Monovalent Vaccines Product Picture
 Figure 4. Combination Vaccines Product Picture
 Figure 5. Global Veterinary Lyme Disease Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Canine
 Figure 7. Feline
 Figure 8. Others
 Figure 9. Veterinary Lyme Disease Vaccine Report Years Considered
 Figure 10. Global Veterinary Lyme Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Veterinary Lyme Disease Vaccine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2020-2031)
 Figure 14. Global Veterinary Lyme Disease Vaccine Sales (2020-2031) & (K Dose)
 Figure 15. Global Veterinary Lyme Disease Vaccine Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 16. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Veterinary Lyme Disease Vaccine Sales Volume Market Share in 2024
 Figure 18. Global Veterinary Lyme Disease Vaccine Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Monovalent Vaccines Revenue Market Share by Manufacturer in 2024
 Figure 21. Combination Vaccines Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2020-2031)
 Figure 23. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2020-2031)
 Figure 24. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2020-2031)
 Figure 25. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2020-2031)
 Figure 26. North America Veterinary Lyme Disease Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 27. North America Veterinary Lyme Disease Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) in 2024
 Figure 29. North America Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Type (2020- 2031)
 Figure 30. North America Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 32. North America Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Veterinary Lyme Disease Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 37. Europe Veterinary Lyme Disease Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Type (2020-2031)
 Figure 40. Europe Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 42. Europe Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 44. France Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Veterinary Lyme Disease Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 49. Asia-Pacific Veterinary Lyme Disease Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Type (2020- 2031)
 Figure 52. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 54. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 59. India Veterinary Lyme Disease Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Veterinary Lyme Disease Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 61. Central and South America Veterinary Lyme Disease Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Type (2021-2031)
 Figure 64. Central and South America Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 66. Central and South America Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Veterinary Lyme Disease Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 70. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Type (2021-2031)
 Figure 73. South America Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 75. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Veterinary Lyme Disease Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 80. Veterinary Lyme Disease Vaccine Industry Chain Mapping
 Figure 81. Regional Veterinary Lyme Disease Vaccine Manufacturing Base Distribution (%)
 Figure 82. Global Veterinary Lyme Disease Vaccine Production Market Share by Region (2020-2031)
 Figure 83. Veterinary Lyme Disease Vaccine Production Process
 Figure 84. Regional Veterinary Lyme Disease Vaccine Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Lyme Disease Vaccine Market Research Report 2025
Veterinary Vaccine Market
Global Veterinary Clostridium Vaccines Market Research Report 2025
Global Lyme Disease Diagnostic Devices Market Research Report 2024
Global Veterinary Biological Vaccines Market Research Report 2025
Global Leptospirosis Vaccine Market Research Report 2024
Global Veterinary Vaccination Market Research Report 2025
Global Livestock Animal Vaccination Market Research Report 2025
Global Lyme Disease Testing Market Research Report 2025
Global Rabies Vaccine for Pets Market Research Report 2024
Global Infectious Bursal Disease Vaccine Market Research Report 2024
Global Livestock Vaccines Market Research Report 2025
Tick borne Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Animal Vaccines Market Research Report 2024
Global Pet Tick Killing Products Market Research Report 2025
Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flea Tick And Heartworm Products Market Research Report 2024
Global Brucellosis Vaccines Market Research Report 2025
Global TB Disease Vaccine Market Research Report 2025
Global Poultry Killed Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions